Presentation TCT 2014 The Case for Selective Use of Prasugrel and Ticagrelor in PCI Patients with Stable CAD Presenter: Matthew J. Price September 14, 2014 REGISTER for free or LOG IN to view this content CAD Pharma Presentation TCT 2014 Up Next Presentation TCT 2014 Does Cilostazol Have a Role as an Antiplatelet Agent in the Contemporary DES Era (and in Triple Therapy Decisions)? Presenter: Frederick Feit September 14, 2014 More slides + Presentation TCT 2014 I Agree, Operate, but the Valve Should Be Replaced! Presenter: James S. Gammie September 14, 2014 Presentation TCT 2014 Beyond the Guidelines: What Is the Optimal Duration of DAPT After Metallic DES Implantation, and Is It Device Specific? Presenter: Marco Valgimigli September 14, 2014 We Recommend
Presentation TCT 2014 Does Cilostazol Have a Role as an Antiplatelet Agent in the Contemporary DES Era (and in Triple Therapy Decisions)? Presenter: Frederick Feit September 14, 2014
Presentation TCT 2014 I Agree, Operate, but the Valve Should Be Replaced! Presenter: James S. Gammie September 14, 2014
Presentation TCT 2014 Beyond the Guidelines: What Is the Optimal Duration of DAPT After Metallic DES Implantation, and Is It Device Specific? Presenter: Marco Valgimigli September 14, 2014